Bio Green Med Solution (BGMS) EBIT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.63 Bn | 133.78 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 64.98 Bn | 59.79 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 57.46 Bn | 52.32 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.39 Bn | 44.39 Bn | - | - |
| 6 | BeOne Medicines | 40.35 Bn | 35.25 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.10 Bn | 27.26 Bn | - | -36.55% |
| 9 | Insmed | 27.44 Bn | 26.27 Bn | 358.27 Mn | 99.51% |
| 10 | Bio Green Med Solution | 5.01 Mn | 1.22 Mn | 79,000.00 | 66.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.53% |
| Mar 31, 2026 | 94.16% |
| Dec 31, 2025 | 40.81% |
| Sep 30, 2025 | 54.43% |
| Jun 30, 2025 | 65.72% |
| Mar 31, 2025 | 3.24% |
| Dec 31, 2024 | 65.90% |
| Sep 30, 2024 | 68.20% |
| Jun 30, 2024 | 38.54% |
| Mar 31, 2024 | 40.50% |
| Dec 31, 2023 | 39.40% |
| Sep 30, 2023 | -5.85% |
| Jun 30, 2023 | -2.49% |
| Mar 31, 2023 | -11.59% |
| Dec 31, 2022 | -40.87% |
| Sep 30, 2022 | -13.38% |
| Jun 30, 2022 | 5.16% |
| Mar 31, 2022 | -52.36% |
| Dec 31, 2021 | -98.20% |
| Sep 30, 2021 | -121.77% |